Key facts
- This page summarizes PERCEPTIVE ADVISORS LLC's Form 4 filing for IsoPlexis Corp.
- 7 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 14 Oct 2021, 17:07.
PERCEPTIVE ADVISORS LLC - 12 Oct 2021 Form 4 Insider Report for IsoPlexis Corp
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 12 Oct 2021
- Net transaction value
- +$12,750,000
- SEC form
- 4
- Accepted by SEC
- 14 Oct 2021, 17:07:50 UTC
- Prior SEC filing
- 07 Oct 2021
- Next SEC filing
- 15 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
PERCEPTIVE ADVISORS LLC filed Form 4 for IsoPlexis Corp on 14 Oct 2021.
Change
- Previous filing in this sequence was filed on 07 Oct 2021.
- Current net transaction value: +$12,750,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ISO
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +2,704,587
- Change %
- Price
- Shares after
- 2,704,587
- Date
- 12 Oct 2021
- Ownership
- By Perceptive Life Sciences Master Fund, Ltd.
- Footnotes
- F1, F2, F5
ISO
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +335,962
- Change %
- Price
- Shares after
- 335,962
- Date
- 12 Oct 2021
- Ownership
- By Perceptive Credit Holdings III, LP
- Footnotes
- F1, F3, F6
ISO
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +204,949
- Change %
- Price
- Shares after
- 204,949
- Date
- 12 Oct 2021
- Ownership
- By PCOF EQ AIV III, LP
- Footnotes
- F1, F4, F7
ISO
transaction
Common Stock
Purchase
- Transaction value
- $12,750,000
- Shares
- +850,000
- Change %
- +31%
- Price
- $15.00*
- Shares after
- 3,554,587
- Date
- 12 Oct 2021
- Ownership
- By Perceptive Life Sciences Master Fund, Ltd.
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ISO
transaction
Derivative
Series D Redeemable Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -325,014
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 12 Oct 2021
- Ownership
- By Perceptive Life Sciences Master Fund, Ltd.
- Underlying class
- Common Stock
- Underlying amount
- 2,600,112
- Exercise price
- Footnotes
- F1, F2
ISO
transaction
Derivative
Series D Redeemable Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -40,373
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 12 Oct 2021
- Ownership
- By Perceptive Credit Holdings III, LP
- Underlying class
- Common Stock
- Underlying amount
- 322,984
- Exercise price
- Footnotes
- F1, F3
ISO
transaction
Derivative
Series D Redeemable Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -24,629
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 12 Oct 2021
- Ownership
- By PCOF EQ AIV III, LP
- Underlying class
- Common Stock
- Underlying amount
- 197,032
- Exercise price
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Shares of Series D Redeemable Convertible Preferred Stock, par value $0.001, of the Issuer (the "Preferred Stock") were convertible on a one-for-eight basis into shares of Common Stock of the Issuer at the option of the holder at any time and automatically converted upon the closing of the Issuer's initial public offering (the "IPO"). The Preferred Stock had no expiration date.
Footnote F2
The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Master Fund"). Perceptive Advisors LLC (the "Advisor") is the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Footnote F3
The securities are directly held by Perceptive Credit Holdings III, LP ("PCH III"). Perceptive Credit Advisors, LLC ("Perceptive Credit") is the investment manager to PCH III. Joseph Edelman is the managing member of Perceptive Credit. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Footnote F4
The securities are directly held by PCOF EQ AIV III, LP ("PCOF"). Perceptive Credit is the investment manager to PCOF. Joseph Edelman is the managing member of Perceptive Credit. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Footnote F5
Includes 104,475 shares of Common Stock issued per dividends accrued to but not including October 12, 2021.
Footnote F6
Includes 12,978 shares of Common Stock issued per dividends accrued to but not including October 12, 2021.
Footnote F7
Includes 7,917 shares of Common Stock issued per dividends accrued to but not including October 12, 2021.